Nhận Dạng Quốc Tế & Đặc Tính Hóa Học
Monoisotopic mass
302.011264286
InChI
InChI=1S/C13H12Cl2O4/c1-3-7(2)13(18)8-4-5-9(12(15)11(8)14)19-6-10(16)17/h4-5H,2-3,6H2,1H3,(H,16,17)
InChI Key
InChIKey=AVOLMBLBETYQHX-UHFFFAOYSA-N
IUPAC Name
2-[2,3-dichloro-4-(2-methylidenebutanoyl)phenoxy]acetic acid
Traditional IUPAC Name
ethacrynic acid
SMILES
CCC(=C)C(=O)C1=C(Cl)C(Cl)=C(OCC(O)=O)C=C1
pKa (strongest acidic)
2.8
Refractivity
72.22 m3·mol-1
Dược Lực Học :
Ethacrynic acid is a monosulfonamyl loop or high ceiling diuretic. Ethacrynic acid acts on the ascending limb of the loop of Henle and on the proximal and distal tubules. Urinary output is usually dose dependent and related to the magnitude of fluid accumulation. Water and electrolyte excretion may be increased several times over that observed with thiazide diuretics, since ethacrynic acid inhibits reabsorption of a much greater proportion of filtered sodium than most other diuretic agents. Therefore, ethacrynic acid is effective in many patients who have significant degrees of renal insufficiency. Ethacrynic acid has little or no effect on glomerular filtration or on renal blood flow, except following pronounced reductions in plasma volume when associated with rapid diuresis.
Cơ Chế Tác Dụng :
A compound that inhibits symport of sodium, potassium, and chloride primarily in the ascending limb of Henle, but also in the proximal and distal tubules. This pharmacological action results in excretion of these ions, increased urinary output, and reduction in extracellular fluid. This compound has been classified as a loop or high ceiling diuretic. [PubChem]
Ethacrynic acid inhibits symport of sodium, potassium, and chloride primarily in the ascending limb of Henle, but also in the proximal and distal tubules. This pharmacological action results in excretion of these ions, increased urinary output, and reduction in extracellular fluid. Diuretics also lower blood pressure initially by reducing plasma and extracellular fluid volume; cardiac output also decreases, explaining its antihypertensive action. Eventually, cardiac output returns to normal with an accompanying decrease in peripheral resistance. Its mode of action does not involve carbonic anhydrase inhibition.
Dược Động Học :
▧ Absorption :
Onset of action is rapid, usually within 30 minutes after an oral dose of ethacrynic acid or within 5 minutes after an intravenous injection of ethacrynic acid.
▧ Protein binding :
> 98%
▧ Metabolism :
Hepatic.
Độc Tính :
Overdosage may lead to excessive diuresis with electrolyte depletion.
Chỉ Định :
For the treatment of high blood pressure and edema caused by diseases like congestive heart failure, liver failure, and kidney failure.
Tương Tác Thuốc :
-
Amikacin
Increased ototoxicity
-
Cisplatin
Increased ototoxicity
-
Colesevelam
Bile acid sequestrants such as colesevelam may decrease the absorption of loop diuretics such as ethacrynic acid. Monitor for decreased serum concentrations/therapeutic effects of loop diuretics if coadministered with bile acid sequestrants. Separating the administration of doses by 2 or more hours may reduce (but not eliminate) the risk of interaction. The manufacturer of colesevelam recommends that drugs should be administered at least 1 hour before or 4 hours after colesevelam.
-
Deslanoside
Possible electrolyte variations and arrhythmias
-
Digitoxin
Possible electrolyte variations and arrhythmias
-
Digoxin
Possible electrolyte variations and arrhythmias
-
Gentamicin
Increased ototoxicity
-
Ginseng
Ginseng may decrease the therapeutic effect of diuretic, ethacrynic acid.
-
Ibuprofen
The NSAID, ibuprofen, may antagonize the diuretic and antihypertensive effects of the loop diuretic, ethacrynic acid.
-
Indacaterol
Concomitant therapy may increase the risk of hypokalemia via intracellular shunting. Monitor for adverse effects and especially for cardiovascular effects associated with hypokalemia.
-
Indomethacin
The NSAID, indomethacin, may decrease the diuretic and antihypertensive effects of the loop diuretic, ethacrynic acid.
-
Kanamycin
Increased ototoxicity
-
Netilmicin
Increased ototoxicity
-
Streptomycin
Increased ototoxicity
-
Sulindac
The NSAID, sulindac, may decrease the diuretic and antihypertensive effects of the loop diuretic, ethacryninc acid.
-
Tobramycin
Increased ototoxicity
-
Trandolapril
The loop diuretic, Ethacrynic acid, may increase the hypotensive effect of Trandolapril. Ethacrynic acid may also increase the nephrotoxicity of Trandolapril.
-
Treprostinil
Additive hypotensive effect. Monitor antihypertensive therapy during concomitant use.
Liều Lượng & Cách Dùng :
Powder, for solution - Intravenous
Tablet - Oral
Dữ Kiện Thương Mại
Nhà Sản Xuất
-
Sản phẩm biệt dược : Crinuryl
-
Sản phẩm biệt dược : Edecril
-
Sản phẩm biệt dược : Edecrin
-
Sản phẩm biệt dược : Hydromedin
-
Sản phẩm biệt dược : Reomax
-
Sản phẩm biệt dược : Taladren
Tài Liệu Tham Khảo Thêm
National Drug Code Directory